PA28γ is a nuclear activator of the 20S proteasome involved in the regulation of several essential cellular processes, such as cell proliferation, apoptosis, nuclear dynamics and cellular stress response. Unlike the 19S regulator of the proteasome, which specifically recognizes ubiquitylated proteins, PA28γ promotes the degradation of several substrates by the proteasome in an ATP-and ubiquitin-independent manner. However its exact mechanisms of action are unclear and likely to involve additional partners that remain to be identified. Here we report the identification of the first cofactor of PA28γ, PIP30/FAM192A. PIP30 binds directly and specifically via its C-terminal end and in an interaction stabilized by casein kinase 2 phosphorylation to both free and 20S proteasome-associated PA28γ. Its recruitment to proteasome-containing complexes depends on PA28γ and its expression increases the association of PA28γ with the 20S proteasome in cells. Further dissection of its possible roles shows that PIP30 alters PA28γ-dependent activation of peptide degradation by the 20S proteasome in vitro and negatively controls in cells the presence of PA28γ in Cajal Bodies by inhibition of its association with the key Cajal body component coilin. Altogether, our data show that PIP30 deeply affects PA28γ interactions with cellular proteins, including 20S proteasome, demonstrating that it is an important regulator of PA28γ in cells and thus a new player in the control of the multiple functions of the proteasome within the nucleus. PIP30/FAM192A, a PA28γ regulator 3
Introduction
The 20S proteasome is a multimeric "barrel-like" protease that bears multiple peptidase (i.e., trypsinlike, caspase-like and chymotrypsin-like) activities inside its internal catalytic chamber (1) . It plays a major role in the regulated degradation of intracellular proteins and requires for its functioning, in most cases, the binding of regulatory complexes to one or both of its ends (1) . Among these regulators, the well-characterized 19S regulatory complex has been shown to associate with the 20S core to form the 26S proteasome that specifically recognizes and degrades polyubiquitylated proteins (2, 3) . Another type of 20S proteasome regulators is the PA28 (also called 11S or REG) family of complexes, which comprises in higher eukaryotes three related proteins (PA28α, -β and -γ) that associate in two distinct complexes (4) . PA28α and PA28β form a cytoplasmic heteroheptamer, PA28αβ (5, 6) , which participates in the immune response by favoring the generation of MHC class I antigens (7, 8) . In contrast, PA28γ is essentially nuclear and forms a homoheptamer (9, 10) . PA28 complexes mediate primarily ubiquitin-independent proteolysis when bound to the 20S proteasome.
However, they are also found in hybrid proteasomes, i.e. 20S proteasome bound to a PA28 heptamer on one end and a 19S complex on the other end (11) and are thus likely to also participate in ATPdependent degradation of ubiquitylated proteins.
Although PA28γ has been little studied, it is involved in various essential cellular pathways, including cell proliferation, through the degradation of the cell cycle inhibitors p21 Cip1 , p16 INK4A and p19 Arf (12) (13) (14) . PA28γ also participates in the Mdm2-dependent degradation of the tumor suppressor p53 (15) . Furthermore, PA28γ -/mice display growth retardation (16) and PA28γ is overexpressed in several types of cancer (17) (18) (19) . In addition to its involvement in the control of cell proliferation, PA28γ is implicated in the regulation of chromosomal stability (20) and plays important roles in nuclear dynamics by modulating the number and size of various nuclear bodies, including Cajal bodies (CBs) (21) , nuclear speckles (22) and PML bodies (23) . It is also involved in the cellular stress response, as it is recruited to double strand break (DSBs) sites upon DNA damage (24) and is required for the UVCinduced dispersion of CBs (21) . PIP30/FAM192A, a PA28γ regulator 5 Despite its important cellular functions, the mechanisms of action of PA28γ, like those of the related PA28αβ complex, remain elusive. It is known that, as the 19S complex, PA28 complexes open the gated pore of the 20S proteasome's α-ring upon binding, thus allowing easier substrate entrance into the catalytic chamber (25) . Artificial peptide substrates commonly used to measure proteasome activities are believed to passively diffuse through the 20S pores, and therefore PA28s' stimulation of their degradation can be explained by 20S-pore opening only. However, how PA28 complexes recruit protein substrates and deliver them to the proteasome is not understood, as these complexes are a priori inert molecules that, unlike the 19S complex, do not possess any ATPase activity that could provide energy and movement to unfold the substrates and inject them into the 20S proteasome (2, 3) .
A likely possibility is thus that PA28 complexes function in proteasome-dependent proteolysis in association with other proteins that remain to be defined.
In this study, we describe the first partner of a PA28 complex, the evolutionary conserved PIP30/FAM192A protein. We show that PIP30 binds with high specificity to PA28γ and enhances its association with the 20S proteasome in cells. Importantly also, PIP30 binding affects PA28γ specificity towards peptide substrates in vitro as well as its interactions with cellular proteins such as the CB marker coilin. Therefore, PIP30 is a major regulator of PA28γ functions and consequently of the nuclear functions of the proteasome.
Experimental procedures
Phylogenetic analyses: Genomes were explored by using Annotation and BLAST search tools available in the Geneious 9.1.7 software package (http://www.geneious.com/). Amino acid sequences were aligned (MAFFT v7.017) and phylogenetic tree was deduced by maximum likelihood analysis (PhyML).
Antibodies: Antibodies and related agents used in this study are described in supplemental Material and Methods.
Production of 20S proteasome and recombinant proteins: Native 20S proteasome was purified from extracts of HeLa cells (IPRACELL, Belgium) using classical chromatographic procedures (26) .
Unless indicated, recombinant PIP30 was produced in E. coli as a 6His-tagged protein and purified by affinity purification followed by proteolytic removal of the tag, anion exchange chromatography and gel filtration ( Fig. S8B ). At the last step, the protein was eluted slightly earlier than the BSA (67kDa) marker, i.e. at an apparent molecular weight larger than twice what was expected. Human recombinant PA28αβ was produced and purified from E. coli, as previously described (27) . Human PA28γ was expressed in E. coli BL21 DE3 CodonPlus. After expression, the PA28γ complex was purified by chromatography as PA28αβ, with some minor modifications of the procedure. Both PA28αβ and PA28γ complexes efficiently activated the peptidase activities of the 20S proteasome. Recombinant GST and GST-PIP30-H201 fusion proteins were produced in bacteria and efficiently purified using glutathione sepharose beads.
Pulldown and immunoprecipitation: For immunoprecipitation of GFP-fusion proteins, U2OS cells were transfected with the indicated constructs. Twenty-four hours post-transfection, cells were homogenized in lysis buffer (25 mM HEPES pH 7.8, 100 mM KCl, 10 mM MgCl 2 , 1 mM EDTA, 1% IGEPAL CA-630, 0.1% Triton X-100, 1 mM DTT, 1 mM ATP, 10% glycerol (v/v)), in the presence of complete EDTA free protease inhibitor cocktail (Roche), for 15 min on ice. After centrifugation at 15000xg for 15 min (4 o C), supernatants were recovered and protein concentration was determined by Bradford assays using BSA as a standard. 20 µl of GFP-TRAP-A® beads (Chromotek) were used per IP, mixed with 200 µg of protein extract and incubated with constant gentle stirring for 1 h at 4 o C.
Beads were washed three times with lysis buffer and boiled in 2X Laemmli sample buffer. Samples were then analyzed by SDS-PAGE and immunoblotting.
Endogenous PIP30 and PA28γ were immunoprecipitated from total cell extracts using anti-PIP30 (rabbit) and anti-PA28γ (rabbit) antibodies, bound to protein A magnetic beads (Dynal, Lake Success, NY) for 2 h at 4°C.
For co-immunoprecipitation of coilin and PA28γ proteins ( Fig 5B) , nuclear extracts were prepared as described in (21) . Briefly, U2OS and PIP30 -/cell pellets were resuspended in hypotonic buffer (10 mM Tris-HCl pH 7.5, 10% glycerol, 4 mM DTT, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM MgCl 2 ) in the presence of complete EDTA-free protease inhibitor cocktail (Roche). IGEPAL CA-630 was then added at the final concentration of 0.5% and cells were incubated on ice for 3 min. After centrifugation at 800xg for 5 min, the nuclei, present in the pellet, were resuspended in digestion buffer (2 mM Tris-HCl pH 8.5, 20% glycerol, 10 mM DTT, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM MgCl 2 , 5 mM CaCl 2 , 1X complete protease inhibitor cocktail) supplemented with 75 U/ml micrococcal nuclease, and then digested for 15 min at 25°C with constant stirring. At the end, an equivalent volume of extraction buffer (2 mM Tris-HCl pH 8.5, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM MgCl 2 , 20 mM EDTA, 0.84 M KCl, 1X complete protease inhibitor cocktail) was added and the mix was incubated on ice for 20 min. Nuclear extracts were clarified by centrifugation for 30 min at 15000xg. Before immunoprecipitation, KCl concentration was reduced to 280 mM, 3 µg of anti-coilin or control IgG were added to 400 µg of nuclear extracts and incubated for 2 h at 4°C. Mass spectrometry analyses: SILAC IPs (endogenous PA28γ and GFP-FAM192A/PIP30) were essentially performed as previously described in (28) . Further details are provided in supplemental section.
Whole human proteasome complexes, including 20S-bound activators and regulators, were immunopurified and analyzed by quantitative mass spectrometry as previously described (29, 30) . 2x10 8 in vivo formaldehyde-crosslinked human cells (HeLa and U937, 3 biological replicates per cell line) were used. For complete nuclear proteasome interactome analysis, U937 cells nuclei were prepared and, before proteasome purification, the purity of nuclear proteins was assessed both by western blot and MS analysis, as detailed earlier (31) . Purified proteasome complexes were analyzed by mass spectrometry as previously described (32) . Further details are provided in supplemental section.
Native electrophoresis in Tris-glycine system: Recombinant protein samples were incubated 5-10 min at room temperature (RT) in reaction buffer (Tris-HCl 20mM, pH 7.5, DTT 1mM, Glycerol 10%
(v/v)), then supplemented with 1µL of native sample buffer (xylene cyanol FF in reaction buffer supplemented with 50% glycerol) and applied on 5% polyacrylamide gel prepared in Tris-Glycine electrophoresis buffer (25mM Tris-HCl pH 8.0, 192mM Glycine, 1mM DTT). Native electrophoresis was performed for 4-5hrs (100V, 4°C). After denaturation in 10X TG-SDS buffer, proteins were transferred on PVDF membrane and immunoblotted.
Surface Plasmon Resonance analysis: Experiments were performed on Biacore 3000 apparatus (GEHealthcare) at 25°C using a flow rate of 50 µl/min in HBS-EP buffer (GE Healthcare). To compare the binding of PA28γ and PA28αβ on 6His-PIP30 recombinant protein, 6His-PIP30 (4500RU)) was captured on anti-HisTag covalently immobilized on a CM5 sensor chip using amine coupling procedure according to the manufacturer's instructions. A control flowcell was obtained with the same chemical procedure without protein. 60µl of PA28γ and PA28αβ (50µg/ml) were injected on His6PIP30 and control flowcells followed by a dissociation step of 400s.
In vitro CK2 phosphorylation assay: GST and GST-PIP30-H201 proteins were incubated with recombinant CK2 according to the manufacturer's instructions. For radioactive kinase assays, 33 For proximity ligation assays (PLA), cells on coverslips were fixed and permeabilized as described in (22) . Coverslips were then blocked in a solution provided by the Duolink® kit. Cells were then incubated with mentioned antibodies as described above. Duolink® In Situ PLA Probe Anti-Rabbit MINUS and Anti-Mouse PLUS and Duolink® In Situ Detection Reagents (Sigma-Aldrich) were used, according to the manufacturer's instructions.
Image acquisition and analysis
Z-stacks and images were acquired with a 63X/1.4 NA or 40X oil immersion objective lenses using widefield microscopes, DM6000 (Leica Microsystems) or Axioimager Z1 or Z2 (Carl Zeiss), equipped with coolSNAP HQ2 cameras (Photometrics). Images were acquired as TIF files using MetaMorph imaging software (Molecular Devices). For CB and PLA dots quantitative analysis, Zstacks were acquired every 0.3 to 0.4µm (Z step) with a range of 10-15 µm to image the whole nuclei.
The number of PLA foci was analyzed with ImageJ. The size, the intensity and the number of Cajal bodies were measured with ImageJ (1.49v), using a specific "macro" that has been created to automatically quantify these different parameters. The script allows creating a mask of DAPI image to isolate the nucleus of each cell and create a maximum intensity projection (MIP) of the 25 Z-stacks.
The mask is used in the MIP to count the number of CB or PLA dots of each nucleus via an appropriate thresholding. The "Analyze Particles" tool of ImageJ was used to calculate the size and the mean gray value of each Cajal body.
Results

FAM192A is a novel partner of both free and 20S proteasome-bound PA28γ that regulates the interaction between PA28γ and 20S proteasome
In order to identify new interactors of PA28γ, we used a high throughput approach combining endogenous PA28γ immunoprecipitation (IP) and SILAC-based quantitative proteomics (28) ( Fig.   S1A , left panel). In this experiment, 68 human protein groups containing at least two unique peptides were quantified and visualized by plotting log 2 (H/L ratio) versus log 2 (H intensity) ( Fig. 1A , Table S1 ).
PA28γ itself was found with a H/L SILAC ratio close to 15. Among PA28γ interactors was FAM192A, a poorly annotated nuclear protein of unknown cellular function, whose expression is induced during skeletal muscle atrophy (33) . FAM192A was also identified with a high SILAC ratio in a GFP-PA28γ pull-down that we performed in parallel (Table S2) Table S3 )). Reciprocal IPs on endogenous proteins showed that at least 70% of each protein coprecipitates with the other (Fig. S1B ). Like PA28γ, FAM192A is nuclear ( Fig. S8A ) and interaction between the two proteins occurs within the nucleus (Fig. S1C ).
Using recombinant FAM192A and PA28γ proteins produced in E. coli, we found that the interaction between PIP30 and PA28γ is direct, as shown for example by native gel electrophoresis (Fig. 1C ) or Surface Plasmon Resonance (SPR) ( Fig. S1D ). SPR showed no interaction between PIP30 and the closely related PA28αβ complex ( Fig. S1D ), demonstrating the high specificity of PA28γ/PIP30 interaction in vitro.
Through parallel approaches, we investigated putative nuclear Proteasome Interacting Proteins by quantitative analysis of proteasome complexes immuno-purified from nuclei of U937 cells using the MCP21 antibody (targeting the α2 subunit of 20S proteasome), as described earlier (31) . As expected, all 20S proteasome and 19S regulatory complex subunits, as well as known proteasome interactors such as PA28γ, PA200 and USP14 were found in this category (abundance ratios (IP 20S / IP control) above 2 and p-value below 0.05 (n=3)) ( Fig. S2A and Table S4 ). Interestingly, the protein FAM192A showed an enrichment factor of 6.4 and a p-value < 5.10 -4 and thus clearly qualifies as a new proteasome interacting protein.
Further quantitative analysis of proteasome-associated proteins after PA28γ knockdown in HeLa cells
showed that FAM192A is recruited on proteasomes in a PA28γ-dependent manner (Fig.1D ). The enrichment in anti-FAM192A immuno-precipitates of all subunits of the 19S regulatory complex (PSMCx and PSMDx) ( Fig. S2B ) demonstrated that FAM192A is also recruited, via its interaction with PA28γ, on hybrid proteasomes.
Interestingly, co-immunoprecipitation of PA28γ with 20S proteasome was significantly (p-value = 0.02) reduced in FAM192A-depleted cells ( Fig. 1D , please note that the scale is in log). Co-IP of wild type and FAM192A -/-U2OS cell extracts showed that FAM192A depletion elicits a 2-fold decrease in PA28γ/α4 interaction ( Fig.1E ). Thus FAM192A promotes the association of PA28γ with the 20S proteasome.
Altogether, our experiments establish that FAM192A is a major direct interactor of proteasome-free and proteasome-bound PA28γ and that it favors the association of PA28γ with the 20S proteasome.
FAM192A is also called NIP30 (NEFA-Interacting Protein 30kD) and/or might refer to a NIP (4hydroxy-5-iodo-3-nitrophenyl acetate) -labeled 30kD protein that interacts with phosphatidylinositol biphosphate (34) . Based on the above experiments, and since it has no clear assigned cellular function, we propose to rename it PIP30, for PA28γ Interacting Protein 30 kDa. This name will be used thereafter in this manuscript.
PA28γ / PIP30 interaction is stabilized by CK2 phosphorylation of PIP30 C-terminus
Evolutionary analyses show that PIP30 sequence is characterized by the presence of three conserved domains: an N-terminal signature domain (pfam10187, also called NIP30 domain, ≈100 amino acids) and two smaller motifs (Fig. S3A ). The pfam10187 domain is found in metazoa as well as in all major eukaryotic supergoups. This allows tracing back PIP30 gene to early stages of eukaryote evolution ( Fig. S3B ), as it is the case for PA28γ (4) . The conserved C-terminal motifs of PIP30 proteins are enriched in phosphorylatable residues, including a completely conserved tyrosine and several serine residues.
Using various truncation mutants, we determined that the last 54 amino acids of PIP30 (aa 201-254, i.e., H201 mutant), are necessary and sufficient for interaction with endogenous PA28γ and that aa 223-230 are critical for the association ( Fig. 2A and S4A ). This C-terminal region includes the highly conserved serine-rich and acidic sequence highlighted in Fig. S3A and contains two SDSE motifs ( Fig. S4B ) that both match the canonical consensus site (S/T-X-X-E/D/pS) for casein kinase 2 (CK2) (35, 36) . Indeed, we found that this region can be phosphorylated by CK2 in vitro (Fig. 2B ).
Phosphorylation is dependent on the integrity of the CK2 consensus sites, as it was reduced when the serine residues S 222 and S 228 were replaced by alanine (mutant SS-AA), and abolished or strongly impaired when the acidic residues within the two CK2 consensus motifs were converted into basic lysine residues (mutants D 223 E 225 -KK and D 229 E 231 -KK, respectively) ( Fig. 2B and S4B ).
In the context of the full length GFP-PIP30 protein, these mutations altered the binding to PA28γ in cells. In a manner parallel to their effects on CK2 phosphorylation in vitro, the acidic mutants abolished or strongly impaired the binding while the SS-AA mutant reduced it (Fig. 2C ). The weaker binding of the SS-AA mutant strongly suggests that phosphorylation is stabilizing PA28γ/PIP30 interaction. Indeed, using purified proteins, PA28γ showed more affinity for CK2-phosphorylated than for non-phosphorylated PIP30 (Fig. 2D ).
To verify that CK2 is the endogenous kinase phosphorylating PIP30, we treated cells with the selective CK2 inhibitor CX-4945 (37) . This treatment revealed a second, faster-migrating band ( Fig.   2E ), suggesting that in cells PIP30 is primarily in a CK2-phosphorylated form. While only a minor fraction of endogenous PIP30 was non-phosphorylated in wild type cells upon CK2 inhibition for 24hrs, it was mainly non-or hypo-phosphorylated in PA28γ -/cells after the same treatment ( Fig. 2E ).
This suggests that, although PIP30 does not require PA28γ for being phosphorylated, the binding to PA28γ protects it from being dephosphorylated. This was confirmed by the fact that λ-phosphatase can dephosphorylate a fraction of immunoprecipitated endogenous PIP30, but not the endogenous PIP30 co-immunoprecipitated with PA28γ ( Fig. S4C ). Finally, after CX-4945 treatment, only the phosphorylated PIP30 was retrieved upon PA28γ immunoprecipitation ( Fig. 2F) , showing that the phosphorylation of PIP30 by CK2 in cells stabilizes its interaction with PA28γ. Altogether our results
show that the C-terminal end of PIP30 protein is critical for its binding to PA28γ and that its phosphorylation by CK2 stabilizes this interaction.
PIP30 controls substrate diffusion to the catalytic chamber of the proteasome
We next assessed whether PIP30 could interfere with the best-known property of PA28γ, i.e. its ability to activate the peptidase activities of the proteasome in vitro.
Using recombinant PIP30 in combination with PA28γ and 20S proteasome, we found that PIP30 differentially altered degradation of a panel of standard proteasome peptide substrates (38) and Ac-nLPnLD-amc (nLPnLD) degradation was partially inhibited, degradation of Boc-LRR-amc (LRR) was almost insensitive to the presence of PIP30 ( Fig. 3A and S5A ). PIP30 had no effect when PA28αβ was used to activate the 20S proteasome in similar experiments (Fig. S5B ). This indicates that PIP30 is not directly affecting 20S proteasome and most likely acts in this assay through its interaction with PA28γ. The differential effects of PIP30 were not correlated with specific proteasome peptidase activities ( Fig.3A ), suggesting that PIP30 is not acting through alteration of the proteasome active sites. To confirm this hypothesis, we used the proteasome activity probe Bodipy TMR-Ahx 3 L 3 VS (a generous gift of Prof. Huib Ovaa), which labels efficiently the β2 (trypsin-like activity) and β5 (chymotrypsin-like activity) subunits of the proteasome (39, 40) . We found that the ratio between β2 and β5 labeling was not altered by PIP30 ( Fig.3B) , showing that the relative activity of both sites is not changed. Therefore, the differential degradation of LRR (β2 substrate) and LLVY (β5 substrate) elicited by PIP30 is most likely due to a differential diffusion rate into the catalytic chamber of the proteasome. This strongly suggests that PIP30 regulates peptide entrance or transit through the channel opened by PA28γ upon binding to the 20S proteasome.
We next assessed whether PIP30 phosphorylation affects its effect on peptide degradation. Comparing non-phosphorylated and CK2-phosphorylated PIP30 (Fig. S8D ), we found that phosphorylation of PIP30 enhanced its inhibitory effects ( Fig. 3C ): For the most affected peptides, phosphorylated PIP30 was able to abrogate the activating effect of PA28γ on their hydrolysis. However, it had a limited effect on other peptides and remained without effect on the basic LRR substrate (Fig. 3C ).
Overall, these data show that PIP30 is able to alter the 20S proteasome-activating properties of PA28γ in vitro. In this process, it seems to act as a phosphorylation-modulated filter that differentially impairs the entrance or the transit of peptide substrates through the PA28γ channel.
PIP30 alters PA28γ functions in Cajal body dynamics
We have previously shown that PA28γ overexpression leads to the disruption of CBs (21) , which are evolutionary conserved coilin-dependent and coilin-rich subnuclear compartments. CBs are involved in the maturation of small nuclear RNPs (snRNPs) and small nucleolar RNPs (snoRNPs) as well as in the processing of histone pre-mRNAs (41, 42) . We thus tested whether PIP30 has also a role in CB dynamics. First, we compared CB number in wild type, PA28γ -/and PIP30 -/-U2OS cells. We found that while 80% of wild type and PA28γ -/-U2OS cells display CBs, only 40% of PIP30 -/cells are CBpositive ( Fig. 4A and 4B ). Furthermore, in cells displaying CBs, the absence of PIP30 leads to a decrease in the average number of CBs per nucleus (Fig.4C ). The effect of PIP30 depletion was rescued by expression of GFP-PIP30, but not of GFP-PIP30 , a mutant that cannot bind to PA28γ ( Fig. 4D ). Together, these results show that PIP30, like PA28γ (21), controls the steady state number of CBs and that this depends on its binding to PA28γ. However, PIP30 and PA28γ do not have the same effects in this process.
In the absence of PIP30, i.e. in siRNA PIP30-depleted or PIP30 knockout cells, but not in control cells, we observed an accumulation of PA28γ in all residual CBs, either identified by coilin ( Fig. 5A) or WRAP53 (another CB marker) staining ( Fig. S6A ). Furthermore, re-expression of GFP-PIP30 in PIP30-depleted cells abrogated the accumulation of PA28γ in CBs (Fig. S6B ). These observations demonstrate that PIP30 inhibits PA28γ subnuclear localization in CBs.
Since PA28γ is known to bind to the key CB component coilin ((21) and Table S2 ), we analyzed whether PIP30 could affect this process. We observed that PIP30 depletion led to an increased interaction of PA28γ with coilin, as seen by co-immunoprecipitation experiments (Fig. 5B ). In line with this observation, in the absence of PIP30, an increased number of dots could be seen by PLA using anti-PA28γ and coilin antibodies, supporting the notion that PIP30 inhibits PA28γ/coilin interaction ( Fig. S7A and B ).
Altogether, these experiments show that PIP30 effect on CBs is mediated through its ability to bind PA28γ and counteract PA28γ association with coilin, confirming that PIP30 indeed functions as an endogenous regulator of PA28γ.
Discussion
Despite the fact that PA28 complexes have long been known, little is understood regarding their roles as proteasome regulators, besides their ability to open upon binding the gated channel of the 20S proteasome. However, since specific protein substrates have been described for PA28γ, it is possible that these regulators are not just passively opening the gate of the 20S proteasome but somehow contribute to substrate selection and possibly unfolding and injection into the 20S core. If true, then it is likely that they work in synergy with other proteins, since by themselves they seem a priori unable to actively promote proteasomal degradation of specific protein substrates. We thus performed various proteomics experiments to characterize proteins associated with PA28γ.
Among the interaction partners of endogenous PA28γ, we found several proteins involved in the regulation of RNA processing (Table 1 ), suggesting an important role of PA28γ in this function.
Although PA28γ interacts with the 20S proteasome, we identified only the α6 subunit (PSMA1) in the conditions used. However, we found all subunits with high H/L ratios when PA28γ pulldowns were performed in the presence of proteasome inhibitors (data not shown), confirming that PA28γ/20S proteasome interaction is labile (31) and is stabilized upon proteasome inhibition (11, 43) .
Importantly, we identified a novel and prominent partner of PA28γ, PIP30/FAM192A. Interaction between PIP30 and PA28γ has already been listed in large-scale proteomics experiment data in drosophila and human (44, 45) . However, our results are the first to validate its biological relevance.
We demonstrated that this interaction is direct and occurs in cells with 20S-proteasome free and bound PA28γ. The interaction is specific for PA28γ since we found no interaction between PIP30 and PA28αβ in vitro. This suggests that interaction may involve the homolog-specific insert, which is the most divergent domain between PA28 paralogs (46) . Importantly we show that the PA28γ-binding region of PIP30 is located in its C-terminal end and that CK2 phosphorylation of a short motif in this region stabilizes its association with PA28γ. Since mutation of serine residues (S 222 and S 228 ) of both typical CK2 targets does not completely abolish binding, it is likely that additional serine residues are phosphorylated by CK2. This is line with the ability of CK2 to catalyze the generation of phosphoserine stretches (36) , and with the report that S 219 , S 221 , S 222 and S 224 of PIP30 are phosphorylated in vivo (Global Proteome Machine, Accession: ENSP00000335808 (47)). The role of these multiple phosphorylation events is not clear. CK2 is indeed an ubiquitous and pleiotropic kinase (48) , and even if its activity has been shown to be positively regulated by the Wnt/β-catenin pathway (49) it is considered to be constitutively active in cells. Our results also suggest an extremely slow turnover of the phosphate groups for the majority of PIP30 bound to PA28γ, probably because steric hindrance makes them inaccessible to phosphatases once the complex is formed. It thus seems unlikely that CK2 phosphorylation of PIP30 is used in cells to dynamically control PIP30/PA28γ interaction.
Comparison of PIP30 and PA28γ distributions within the eukaryotic phylogenetic tree (Fig. S3B) shows that their presence or absence is not correlated. For example, in all Ascomycota including S. cerevisiae, PIP30 is present while PA28γ has been lost. This indicates that the two proteins may function independently from each other. However, in human cells, more than 70% of PA28γ and PIP30/FAM192A are associated in the same complex ( Fig. S1B ), suggesting that they cooperate in most of their functions.
In line with this assertion, our data show that PIP30 regulates the function of PA28γ as a proteasome regulator, since its invalidation halves the intracellular level of the PA28γ / 20S proteasome complex ( Fig. 1D, E) . However, since the 20S proteasome / PA28γ complex only represents ≤ 5% of the total 20S proteasome (29) , it is difficult to predict the biological impact of this effect. Based on our in vitro analyses showing that PIP30 inhibits the degradation of some peptides by reconstituted 20S proteasome / PA28γ complexes but is permissive for others ( Fig. 3) , it is tempting to speculate that PIP30 acts as a molecular sieve that hinders entrance of some protein substrates into the PA28γ channel while being neutral for others. The likely binding of PIP30 to the PA28γ specific insert that forms a loop located close to the pore of the complex (25, 50) is compatible with such a molecular sieve role. Ongoing structure/functions analyses aiming at precisely mapping where PIP30 interacts with PA28γ will help to answer these questions.
A second illustration of the role of PIP30 as a PA28γ regulator is the demonstration that both proteins intimately cooperate in the regulation of CB integrity. Indeed, PIP30 depletion leads to a strong decrease in the number of CBs and to an increased interaction between coilin and PA28γ (Fig.5B,   S7A ,B). This mimics the phenotype induced by PA28γ overexpression ((21), Table S3 ). PIP30 depletion also elicits the accumulation of PA28γ in residual CBs, while PA28γ is usually not detectable in these structures. To our knowledge, PA28γ has only been observed in CBs of motor neurons from patients with Type I spinal muscular atrophy (SMA) (51) . In these pathologic neurons, the assembly of CBs is impaired, due to the lack of the Survival Motor Neuron (SMN) Together, the effects of PIP30 deletion on CB integrity suggest that increasing the levels of PA28γ / coilin complexes negatively regulates the number of CBs and that PIP30 inhibits the association between PA28γ and coilin. This model supports the idea that PA28γ overexpression leads to CB destabilization by overwhelming PIP30 inhibition and therefore that the equilibrium between free PA28γ and PIP30-bound PA28γ is an important parameter in this process. In this regard, it is interesting to note that CB fragmentation upon UV-C treatment is associated with the concomitant increase in PA28γ and its recruitment to coilin (21) . If PIP30 levels are limiting in cells, the resulting excess of PIP30-free PA28γ might be sufficient to interact with coilin and induce CB fragmentation.
Altogether, the results presented here show that PIP30 is an important partner of PA28γ that regulates its interactome, e.g. by stabilizing its interaction with the 20S proteasome and inhibiting its interaction with coilin. Since most PA28γ is bound to PIP30 in standard cell culture conditions, it is clear that PIP30 must now be taken into account when studying PA28γ. Although much remains to be understood regarding PIP30 biological functions, our results represent a significant breakthrough since HR110PA-1 vector using Turbofect (Thermofischer) (58). PSME3/PA28γ -/cells were generated by cotransfection of PSME3/PA28γ sgGuide and pX459 vectors. Both PIP30 and PSME3/PA28γ -/cells were selected with puromycine (1 µg/ml). Single clones were then expanded and analyzed by western blotting using PIP30 and PA28γ antibodies. Of note, the KO cell lines, made using the CAS9/CRISPR gene editing technology (Fig. S8C ) did not show significant proliferation defects, as assessed by video-microscopy and FACS analysis (data not shown). Thus PIP30, as established previously for PA28γ, is also not essential for cell viability in normal growth conditions and does not accumulate at specific cell-cycle stage.
Figure legends
RNA interference: Silencing RNAs were obtained from Dharmacon: On target plus Human PSME3 siRNA 5nmol (J-012133-05-0005) and On target plus SMARTpool Human NIP30 5 nmol (L-014528-01-0005). Silencing RNA targeting coilin was obtained from IDT (AGAGTCGAGAGAACAATA).
Proteomics analyses: For SILAC IPs (28) 2) software, as described in (28) .
For purified proteasome complexes mass spectrometry analyses, protein eluates were precipitated with trichloroacetic acid, heated in Laemmli buffer (95°C, 30 min), and loaded on a 12% SDS-PAGE gel.
For one-shot analysis of the entire mixture, no fractionation was performed, and the electrophoretic migration was stopped as soon as the protein sample entered the separating gel. The gel was briefly stained with Coomassie blue and a single band, containing the whole sample, was cut and processed.
For shotgun analysis, electrophoretic migration was performed in order to fractionate the protein eluate into 10 gel bands. Proteins were in-gel digested with trypsin and the resulting peptides mixtures were analyzed by nano-LC-MS/MS using an UltiMate 3000 system (Dionex) coupled to a LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). Five microliters of each peptide sample corresponding to an equivalent initial quantity of proteins of 2.5 µg were loaded on a C18 precolumn (300 µm inner diameter × 5 mm; Dionex) at 20 µl/min in 5% acetonitrile, 0.05% trifluoroacetic acid. After 5 min of desalting, the precolumn was switched online with the analytical C18 column (75 µm inner diameter × 15 cm; PepMap C18, Dionex) equilibrated in 95% solvent A (5% acetonitrile, 0.2% formic acid) and 5% solvent B (80% acetonitrile, 0.2% formic acid). Peptides were eluted using a 5-50% gradient of solvent B during 160 min at a 300 nl/min flow rate. The mass spectrometer was operated in data-dependent acquisition mode. Detailed MS operation settings and data analyses are described elsewhere (30) . and coilin were examined in asynchronous growing U2OS cells by a PLA approach, using anti-PIP30
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(rabbit) and anti-coilin (mouse) antibodies. Bars, 10 µm. 
